Insider Transactions in Q1 2022 at Rubius Therapeutics, Inc. (RUBY)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Laurence A. Turka Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,517
-33.84%
|
$15,102
$6.57 P/Share
|
|
Feb 01
2022
|
Maiken Keson Brookes CLO & Corp. Secretary |
SELL
Open market or private sale
|
Direct |
2,732
-33.83%
|
$16,392
$6.57 P/Share
|
|
Feb 01
2022
|
Pablo J Cagnoni Director |
SELL
Open market or private sale
|
Direct |
6,730
-15.93%
|
$40,380
$6.57 P/Share
|
|
Jan 29
2022
|
Laurence A. Turka Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+50.0%
|
-
|
|
Jan 29
2022
|
Maiken Keson Brookes CLO & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
8,075
+50.0%
|
-
|
|
Jan 29
2022
|
Pablo J Cagnoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+33.46%
|
-
|